AI-focused biotech Deepcell is partnering with Nvidia to expand its use of generative AI in cell biology, the company announced Monday afternoon. The partnership — unveiled at the JP Morgan Healthcare ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced a research collaboration with ...
Now, with the European Union Health Technology Assessment (HTA) regulation coming into force as part of the required Joint Clinical Assessment (JCA) for oncology and advanced therapy medicinal ...
OXFORD, England--(BUSINESS WIRE)--British techbio innovator Etcembly is coming out of stealth mode, kickstarting the next generation of immunotherapies with a pipeline of best-in-class T cell receptor ...
Similar to generative AI models that create pictures based on a photo, or a textual description of a motive, in the style of different artists, the VirtualMultiplexer produces virtual colorations for ...
Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer Precision oncology in non–small ...
Generative artificial intelligence has become widely accepted as a tool that increases productivity. Yet the technology is far from mature. Large language models advance rapidly from one generation to ...